Filing Details
- Accession Number:
- 0001583648-22-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-16 20:19:05
- Reporting Period:
- 2022-05-13
- Accepted Time:
- 2022-05-16 20:19:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1583648 | Pieris Pharmaceuticals Inc. | PIRS | Pharmaceutical Preparations (2834) | 300784346 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1875267 | Tim Demuth | 255 State St. 9Th Floor Boston MA 02109 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-13 | 6,000 | $1.71 | 6,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Purchase price was 1.65 Euros per share which was converted into dollars using the noon buying rate of 1.00 Euro to $1.03745 based on information provided on May 13, 2022 via Xignite.